Lymphedema affects up to 250 million people worldwide. The understanding of the
pathophysiology of the condition, however, is incomplete and a cure remains elusive. A …

Advances in our understanding of the lymphatic system and the pathogenesis of
lymphedema have resulted in the development of effective surgical treatments. Vascularized …

Introduction: Analysis of quality of life (QOL) outcomes is an important aspect of
lymphedema treatment since this disease can substantially impact QOL in affected …

Background: Patients with breast cancer–related lymphedema can be treated with a
simultaneous deep inferior epigastric perforator (DIEP) flap, vascularized inguinal lymph …

Background A growing body of evidence supports the efficacy of surgical treatments for
lymphedema. This study reports the outcomes of vascularized lymph node transplantation …

LVA and vascularized lymph node transfer VLNT are established lymphedema treatments.
However, LVA is only effective for early disease and VLNT can cause donor-site …

Significance: Lymphedema is chronic limb swelling from lymphatic dysfunction. The
condition affects up to 250 million people worldwide. In breast cancer patients, lymphedema …

Abstract Purpose of Review For patients who have or may develop lymphedema due to
oncologic resection, surgical options are available to prevent and treat this chronic disease …

Introduction: The purpose of this study was to evaluate the most commonly used
preoperative assessment tools for patients undergoing surgical treatment for secondary …

Background: The vascularized groin and submental lymph node (VGLN and VSLN) flaps are
valuable options in the treatment of lymphedema. This study was to compare outcomes …